{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:02:05Z","timestamp":1780380125068,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04248-3","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:36:05Z","timestamp":1753882565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology and economic burden of end-stage kidney disease by age, gender, and province among Iranian Hajj pilgrims in 2012-22: a retrospective study of 469,581 participants"],"prefix":"10.1186","volume":"26","author":[{"given":"Pirhossein","family":"Kolivand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samad","family":"Azari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Saffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher","family":"Doroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Marashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Behzadifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshte","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Rajaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Raei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Jafar","family":"Ehsanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Parvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid Keyvan","family":"Khesal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Saberian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"4248_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijid.2016.06.013","volume":"47","author":"S Shafi","year":"2016","unstructured":"Shafi S, Dar O, Khan M, Khan M, Azhar EI, McCloskey B, Zumla A, Petersen E. The annual Hajj pilgrimage-minimizing the risk of ill health in pilgrims from Europe and opportunity for driving the best prevention and health promotion guidelines. Int J Infect Dis. 2016;47:79\u201382. Epub 2016 Jun 22. PMID: 27343984; PMCID: PMC7110525.","journal-title":"Int J Infect Dis"},{"key":"4248_CR2","doi-asserted-by":"publisher","unstructured":"Ahmed QA, Ebrahim S, Memish ZA. From Hajj services to mass gathering medicine: Saudi Arabia formalizes a novel discipline. Travel Med Infect Dis 2019 Mar-Apr;28:105\u20136. https:\/\/doi.org\/10.1016\/j.tmaid.2018.07.007. Epub 2018 Jul 18. PMID: 30012471; PMCID: PMC7128817.","DOI":"10.1016\/j.tmaid.2018.07.007"},{"key":"4248_CR3","doi-asserted-by":"publisher","first-page":"1451591","DOI":"10.3389\/fpubh.2025.1451591","volume":"13","author":"P Kolivand","year":"2025","unstructured":"Kolivand P, Saberian P, Arabloo J, Namdar P, Doroudi T, Marashi A, Behzadifar M, Karimi F, Rajaei S, Raei B, Ehsanzadeh SJ. Hospitalization, mortality, and health service delivery pattern among Iranian Hajj pilgrims by age, sex, and Province in 2013\u201322. Front Public Health. 2025;13:1451591.","journal-title":"Front Public Health"},{"key":"4248_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s10198-016-0830-1","volume":"18","author":"G Turchetti","year":"2017","unstructured":"Turchetti G, Bellelli S, Amato M, Bianchi S, Conti P, Cupisti A, et al. The social cost of chronic kidney disease in Italy. Eur J Health Econ. 2017;18:847\u201358.","journal-title":"Eur J Health Econ"},{"issue":"10","key":"4248_CR5","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1007\/s12325-023-02608-9","volume":"40","author":"V Jha","year":"2023","unstructured":"Jha V, Al-Ghamdi SMG, Li G, Wu MS, Stafylas P, Retat L, Card-Gowers J, Barone S, Cabrera C, Garcia Sanchez JJ. Global economic burden associated with chronic kidney disease: A pragmatic review of medical costs for the inside CKD research programme. Adv Ther. 2023;40(10):4405\u201320. https:\/\/doi.org\/10.1007\/s12325-023-02608-9. Epub 2023 Jul 26. PMID: 37493856; PMCID: PMC10499937.","journal-title":"Adv Ther"},{"key":"4248_CR6","doi-asserted-by":"publisher","unstructured":"Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96(6):414-422D. https:\/\/doi.org\/10.2471\/BLT.17.206441. Epub 2018 Apr 20. PMID: 29904224; PMCID: PMC5996218.","DOI":"10.2471\/BLT.17.206441"},{"issue":"7","key":"4248_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong AC, Tummalapalli SL, Ortiz A, Fogo AB, Fliser D, Roy-Chaudhury P, Fontana M, Nangaku M, Wanner C. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20(7):473\u201385.","journal-title":"Nat Rev Nephrol"},{"issue":"10 Suppl","key":"4248_CR8","first-page":"S163","volume":"23","author":"L Golestaneh","year":"2017","unstructured":"Golestaneh L, Alvarez PJ, Reaven NL, Funk SE, McGaughey KJ, Romero A, et al. All-cause costs increase exponentially with increased chronic kidney disease stage. Am J Manag Care. 2017;23(10 Suppl):S163\u201372.","journal-title":"Am J Manag Care"},{"issue":"1","key":"4248_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-9-44","volume":"9","author":"F Hosseinpanah","year":"2009","unstructured":"Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in iran: a large population-based study. BMC Public Health. 2009;9(1):1\u20138.","journal-title":"BMC Public Health"},{"issue":"1","key":"4248_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/kisup.2012.64","volume":"3","author":"A Levin","year":"2013","unstructured":"Levin A, Bilous R, Coresh J. Chapter 1: definition and classification of CKD. Kidney Int Suppl. 2013;3(1):19\u201362.","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"4248_CR11","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3390\/jcm8091323","volume":"8","author":"I Acosta-Ochoa","year":"2019","unstructured":"Acosta-Ochoa I, Bustamante-Munguira J, Mendiluce-Herrero A, Bustamante-Bustamante J, Coca-Rojo A. Impact on outcomes across KDIGO-2012 AKI criteria according to baseline renal function. J Clin Med. 2019;8(9):1323.","journal-title":"J Clin Med"},{"issue":"12","key":"4248_CR12","first-page":"CD004542","volume":"12","author":"P Natale","year":"2019","unstructured":"Natale P, Palmer SC, Ruospo M, Saglimbene VM, Rabindranath KS, Strippoli GF. Psychosocial interventions for preventing and treating depression in dialysis patients. Cochrane Database Syst Rev. 2019;12(12):CD004542.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"4248_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1592\/phco.31.1.9","volume":"31","author":"KL Kier","year":"2011","unstructured":"Kier KL. Biostatistical applications in epidemiology. Pharmacotherapy. 2011;31(1):9\u201322.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"4248_CR14","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1186\/s12913-023-10105-6","volume":"23","author":"L Schumacher","year":"2023","unstructured":"Schumacher L, Dhif Y, Bonnabry P, Widmer N. Managing the COVID-19 health crisis: a survey of Swiss hospital pharmacies. BMC Health Serv Res. 2023;23(1):1134.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"4248_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.30881\/beij.00005","volume":"1","author":"A Sanyaolu","year":"2018","unstructured":"Sanyaolu A, Okorie C, Annan R, Turkey H, Akhtar N, Gray F, et al. Epidemiology and management of chronic renal failure: a global public health problem. Biostatistics Epidemiol Int J. 2018;1(1):11\u20136.","journal-title":"Biostatistics Epidemiol Int J"},{"issue":"6","key":"4248_CR16","first-page":"1066","volume":"21","author":"AO Alsuwaida","year":"2010","unstructured":"Alsuwaida AO, Farag YM, Al Sayyari AA, Mousa D, Alhejaili F, Al-Harbi A, et al. Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators)-a pilot study. Saudi J Kidney Dis Transplantation. 2010;21(6):1066\u201372.","journal-title":"Saudi J Kidney Dis Transplantation"},{"issue":"5","key":"4248_CR17","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ki.2015.230","volume":"88","author":"KT Mills","year":"2015","unstructured":"Mills KT, Xu Y, Zhang W, Bundy JD, Chen C-S, Kelly TN, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950\u20137.","journal-title":"Kidney Int"},{"issue":"7","key":"4248_CR18","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O\u2019Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease\u2013a systematic review and meta-analysis. PLoS ONE. 2016;11(7):e0158765.","journal-title":"PLoS ONE"},{"issue":"6","key":"4248_CR19","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/1744-9987.12716","volume":"22","author":"S Bouya","year":"2018","unstructured":"Bouya S, Balouchi A, Rafiemanesh H, Hesaraki M. Prevalence of chronic kidney disease in Iranian general population: A meta-analysis and systematic review. Therapeutic Apheresis dialysis. 2018;22(6):594\u20139.","journal-title":"Therapeutic Apheresis dialysis"},{"issue":"5","key":"4248_CR20","doi-asserted-by":"publisher","first-page":"e0176540","DOI":"10.1371\/journal.pone.0176540","volume":"12","author":"SG Sepanlou","year":"2017","unstructured":"Sepanlou SG, Barahimi H, Najafi I, Kamangar F, Poustchi H, Shakeri R, et al. Prevalence and determinants of chronic kidney disease in Northeast of iran: results of the Golestan cohort study. PLoS ONE. 2017;12(5):e0176540.","journal-title":"PLoS ONE"},{"key":"4248_CR21","doi-asserted-by":"publisher","first-page":"100099","DOI":"10.1016\/j.dialog.2023.100099","volume":"2","author":"KM Alrufaidi","year":"2023","unstructured":"Alrufaidi KM, Nouh RM, Alkhalaf AA, AlGhamdi NM, Alshehri HZ, Alotaibi AM, et al. Prevalence of emergency cases among pilgrims presenting at King Abdulaziz international airport health care center at Hajj terminal, jeddah, Saudi Arabia during Hajj season, 1440 H\u20132019. Dialogues Health. 2023;2:100099.","journal-title":"Dialogues Health"},{"issue":"3","key":"4248_CR22","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/ijerph18031155","volume":"18","author":"S Yezli","year":"2021","unstructured":"Yezli S, Mushi A, Almuzaini Y, Balkhi B, Yassin Y, Khan A. Prevalence of diabetes and hypertension among Hajj pilgrims: a systematic review. Int J Environ Res Public Health. 2021;18(3):1155.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"4248_CR23","first-page":"71","volume":"4","author":"MT Hollisaz","year":"2010","unstructured":"Hollisaz MT, Pourheidari G, Saghafinia M, Khanipour-Roshan S, Assari S. Hospital admission due to nephrological conditions during Hajj. Iran J Kidney Dis. 2010;4(1):71\u20133.","journal-title":"Iran J Kidney Dis"},{"key":"4248_CR24","doi-asserted-by":"crossref","unstructured":"Gaddoury MA, Armenian HK. Epidemiology of Hajj pilgrimage mortality: analysis for potential intervention. J Infect Public Health. 2023.","DOI":"10.1016\/j.jiph.2023.05.021"},{"issue":"1","key":"4248_CR25","first-page":"99","volume":"22","author":"MR Safarinejad","year":"2009","unstructured":"Safarinejad MR. The epidemiology of adult chronic kidney disease in a population-based study in iran: prevalence and associated risk factors. JN J Nephrol. 2009;22(1):99.","journal-title":"JN J Nephrol"},{"issue":"17","key":"4248_CR26","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the united States. JAMA. 2007;298(17):2038\u201347.","journal-title":"JAMA"},{"issue":"9818","key":"4248_CR27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in china: a cross-sectional survey. Lancet. 2012;379(9818):815\u201322.","journal-title":"Lancet"},{"issue":"1","key":"4248_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000355760","volume":"38","author":"K Nitta","year":"2014","unstructured":"Nitta K, Okada K, Yanai M, Takahashi S. Aging and chronic kidney disease. Kidney Blood Press Res. 2014;38(1):109\u201320.","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"4248_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000489897","volume":"139","author":"B Bikbov","year":"2018","unstructured":"Bikbov B, Perico N, Remuzzi G, Group GGDE. Disparities in chronic kidney disease prevalence among males and females in 195 countries: analysis of the global burden of disease 2016 study. Nephron. 2018;139(4):313\u20138.","journal-title":"Nephron"},{"issue":"2","key":"4248_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.33590\/emj\/10312319","volume":"1","author":"I Goldberg","year":"2016","unstructured":"Goldberg I, Krause I. The role of gender in chronic kidney disease. Emj. 2016;1(2):58\u201364.","journal-title":"Emj"},{"issue":"12","key":"4248_CR31","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41581-019-0208-6","volume":"15","author":"CN Bairey Merz","year":"2019","unstructured":"Bairey Merz CN, Dember LM, Ingelfinger JR, Vinson A, Neugarten J, Sandberg KL, et al. Sex and the kidneys: current Understanding and research opportunities. Nat Rev Nephrol. 2019;15(12):776\u201383.","journal-title":"Nat Rev Nephrol"},{"key":"4248_CR32","doi-asserted-by":"crossref","unstructured":"Neugarten J, Golestaneh L, editors. Influence of sex on the progression of chronic kidney disease. Mayo Clinic Proceedings; 2019: Elsevier.","DOI":"10.1016\/j.mayocp.2018.12.024"},{"issue":"1","key":"4248_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12882-022-02832-5","volume":"23","author":"A Dehghani","year":"2022","unstructured":"Dehghani A, Alishavandi S, Nourimajalan N, Fallahzadeh H, Rahmanian V. Prevalence of chronic kidney diseases and its determinants among Iranian adults: results of the first phase of Shahedieh cohort study. BMC Nephrol. 2022;23(1):203.","journal-title":"BMC Nephrol"},{"issue":"9981","key":"4248_CR34","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975\u201382.","journal-title":"Lancet"},{"key":"4248_CR35","unstructured":"System USRD. 2018 USRDS annual data report: epidemiology of kidney disease in the United States. 2018."},{"issue":"1","key":"4248_CR36","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1016\/j.kisu.2019.11.010","volume":"10","author":"C-W Yang","year":"2020","unstructured":"Yang C-W, Harris DC, Luyckx VA, Nangaku M, Hou FF, Garcia GG, et al. Global case studies for chronic kidney disease\/end-stage kidney disease care. Kidney Int Supplements. 2020;10(1):e24\u201348.","journal-title":"Kidney Int Supplements"},{"issue":"1","key":"4248_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.kint.2018.08.019","volume":"95","author":"B Caplin","year":"2019","unstructured":"Caplin B, Yang C-W, Anand S, Levin A, Madero M, Saran R, et al. The international society of nephrology\u2019s international consortium of collaborators on chronic kidney disease of unknown etiology: report of the working group on approaches to population-level detection strategies and recommendations for a minimum dataset. Kidney Int. 2019;95(1):4\u201310.","journal-title":"Kidney Int"},{"issue":"8","key":"4248_CR38","doi-asserted-by":"publisher","first-page":"e72860","DOI":"10.1371\/journal.pone.0072860","volume":"8","author":"S Anand","year":"2013","unstructured":"Anand S, Bitton A, Gaziano T. The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS ONE. 2013;8(8):e72860.","journal-title":"PLoS ONE"},{"issue":"3","key":"4248_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2215\/CJN.02550310","volume":"6","author":"RJ Muehrer","year":"2011","unstructured":"Muehrer RJ, Schatell D, Witten B, Gangnon R, Becker BN, Hofmann RM. Factors affecting employment at initiation of dialysis. Clin J Am Soc Nephrology: CJASN. 2011;6(3):489.","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"issue":"11","key":"4248_CR40","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.2215\/CJN.03980510","volume":"5","author":"NG Kutner","year":"2010","unstructured":"Kutner NG, Zhang R, Huang Y, Johansen KL. Depressed mood, usual activity level, and continued employment after starting dialysis. Clin J Am Soc Nephrology: CJASN. 2010;5(11):2040.","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"key":"4248_CR41","doi-asserted-by":"crossref","unstructured":"Wang V, Vilme H, Maciejewski ML, Boulware LE, editors. The economic burden of chronic kidney disease and end-stage renal disease. Seminars in nephrology. Elsevier; 2016.","DOI":"10.1016\/j.semnephrol.2016.05.008"},{"issue":"1","key":"4248_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cegh.2019.07.001","volume":"8","author":"A Moradpour","year":"2020","unstructured":"Moradpour A, Hadian M, Tavakkoli M. Economic evaluation of end stage renal disease treatments in Iran. Clin Epidemiol Global Health. 2020;8(1):199\u2013204.","journal-title":"Clin Epidemiol Global Health"},{"issue":"2","key":"4248_CR43","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1681\/ASN.V112319","volume":"11","author":"J Neugarten","year":"2000","unstructured":"Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000;11(2):319\u201329.","journal-title":"J Am Soc Nephrol"},{"key":"4248_CR44","unstructured":"Gatmiri SM, Shamspour N, Minoo FS, Pezeshki ML-PL, Shamspour N, Tabatabei A. Evaluation of Iranian CRF and ESRD patients admitted to medical centers of Mecca & Medina in Hajj travel of 2012 & 2013; causes & outcome. Iran Red Crescent Med J. 2020;22(9)."},{"issue":"10041","key":"4248_CR45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(16)30448-2","volume":"388","author":"BM Robinson","year":"2016","unstructured":"Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet. 2016;388(10041):294\u2013306.","journal-title":"Lancet"},{"issue":"3","key":"4248_CR46","first-page":"501","volume":"20","author":"L Malekmakan","year":"2009","unstructured":"Malekmakan L, Haghpanah S, Pakfetrat M, Malekmakan A, Khajehdehi P. Causes of chronic renal failure among Iranian Hemodialysis patients. Saudi J Kidney Dis Transplantation. 2009;20(3):501\u20134.","journal-title":"Saudi J Kidney Dis Transplantation"},{"issue":"6","key":"4248_CR47","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.4103\/1319-2442.248307","volume":"29","author":"S Imtiaz","year":"2018","unstructured":"Imtiaz S, Salman B, Qureshi R, Drohlia MF, Ahmad A. A review of the epidemiology of chronic kidney disease in pakistan: A global and regional perspective. Saudi J Kidney Dis Transplantation. 2018;29(6):1441\u201351.","journal-title":"Saudi J Kidney Dis Transplantation"},{"key":"4248_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2369-14-114","volume":"14","author":"AK Singh","year":"2013","unstructured":"Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SRK, Acharya VN, et al. Epidemiology and risk factors of chronic kidney disease in India\u2013results from the SEEK (Screening and early evaluation of kidney Disease) study. BMC Nephrol. 2013;14:1\u201310.","journal-title":"BMC Nephrol"},{"key":"4248_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijid.2016.06.013","volume":"47","author":"S Shafi","year":"2016","unstructured":"Shafi S, Dar O, Khan M, Khan M, Azhar EI, McCloskey B, et al. The annual Hajj pilgrimage\u2014minimizing the risk of ill health in pilgrims from Europe and opportunity for driving the best prevention and health promotion guidelines. Int J Infect Dis. 2016;47:79\u201382.","journal-title":"Int J Infect Dis"},{"issue":"13","key":"4248_CR50","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294\u2013304.","journal-title":"JAMA"},{"issue":"3","key":"4248_CR51","doi-asserted-by":"publisher","first-page":"e0230512","DOI":"10.1371\/journal.pone.0230512","volume":"15","author":"S Elshahat","year":"2020","unstructured":"Elshahat S, Cockwell P, Maxwell AP, Griffin M, O\u2019Brien T, O\u2019Neill C. The impact of chronic kidney disease on developed countries from a health economics perspective: a systematic scoping review. PLoS ONE. 2020;15(3):e0230512.","journal-title":"PLoS ONE"},{"issue":"9","key":"4248_CR52","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/sj.ki.5002459","volume":"72","author":"J Zelmer","year":"2007","unstructured":"Zelmer J. The economic burden of end-stage renal disease in Canada. Kidney Int. 2007;72(9):1122\u20139.","journal-title":"Kidney Int"},{"key":"4248_CR53","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s40620-017-0380-3","volume":"30","author":"S-H Kim","year":"2017","unstructured":"Kim S-H, Jo M-W, Go D-S, Ryu D-R, Park J. Economic burden of chronic kidney disease in Korea using National sample cohort. J Nephrol. 2017;30:787\u201393.","journal-title":"J Nephrol"},{"issue":"10","key":"4248_CR54","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1007\/s12325-023-02608-9","volume":"40","author":"V Jha","year":"2023","unstructured":"Jha V, Al-Ghamdi SM, Li G, Wu M-S, Stafylas P, Retat L, et al. Global economic burden associated with chronic kidney disease: a pragmatic review of medical costs for the inside CKD research programme. Adv Therapy. 2023;40(10):4405\u201320.","journal-title":"Adv Therapy"},{"key":"4248_CR55","doi-asserted-by":"crossref","unstructured":"Garc\u00eda GG, Iyengar A, Kaze F, Kierans C, Padilla-Altamira C, Luyckx VA, editors. Sex and gender differences in chronic kidney disease and access to care around the globe. Seminars in nephrology. Elsevier; 2022.","DOI":"10.1016\/j.semnephrol.2022.04.001"},{"issue":"7","key":"4248_CR56","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/03007995.2021.1927690","volume":"37","author":"C Willey","year":"2021","unstructured":"Willey C, Gauthier-Loiselle M, Cloutier M, Shi S, Maitland J, Stellhorn R, et al. Regional variations in prevalence and severity of autosomal dominant polycystic kidney disease in the united States. Curr Med Res Opin. 2021;37(7):1155\u201362.","journal-title":"Curr Med Res Opin"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04248-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04248-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04248-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T07:48:41Z","timestamp":1757317721000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04248-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4248"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04248-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted under the ethical approval granted by the Institutional Review Board (IRB) of the Iranian Red Crescent Society (IRCS), with the approval code IR.RCS.REC.1401.022. The research utilized anonymized, pooled data extracted from routine medical records held in the IRCS database. As the study did not involve any direct contact or intervention with participants, and only used de-identified secondary data, the Ethics Committee of the Iranian Red Crescent Society (IRCS) waived the requirement for obtaining informed consent from individual participants in accordance with national regulations and IRCS policies. Furthermore, this study was conducted in full compliance with the ethical principles of the Declaration of Helsinki, ensuring that all research involving human data adhered to internationally recognized ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"424"}}